Compounds for treating cystic fibrosis
US10414768B2 · kind B2 · utility
0Cited by
8References
6Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Dec 4, 2015 |
| Grant date | Sep 17, 2019 |
| Priority date | — |
| Expiry date | Dec 4, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D473/40
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to compounds of Formula (I) or pharmaceutically acceptable enantiomers, salts, solvates or prodrugs thereof. The invention further relates to the use of the compounds of Formula (I) for the treatment of cystic fibrosis. The invention also relates to a process for manufacturing compounds of Formula (I).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.